How much funding has Reven Pharmaceuticals raised?

Reven Pharmaceuticals has disclosed $6.3M raised across 2 rounds.

Where is Reven Pharmaceuticals headquartered?

Reven Pharmaceuticals is headquartered in Sarasota, US.

Reven Pharmaceuticals

Sarasota, US · Florida corporation

Find your way into Reven Pharmaceuticals

Reven is a biotech company developing RJX technology to address treatment needs for patients with limited therapeutic options. The company has conducted over a decade of research, including FDA-approved clinical studies and is currently investigating the technology's applications across multiple treatment modalities.

Biotech Healthtech Medical Devices

Founders & leadership

Peter B. LangeExecutive

Brian DenommeExecutive

Michael A. VolkinDirector and Chief Strategy Officer

Michael HandleyinChief Development Officer and Director2012–2019Executive Officer at Tivic Health Systems

Reported raises · per SEC filings

Form D private placements

$6.3M disclosed across 2 rounds · 2013–2014

▶$4.4MraisedFeb 2015 · 48 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Peter B. LangeExecutive Officer, Director
Brian DenommeExecutive Officer, Director
Michael A. VolkExecutive Officer
Michael HandleyExecutive Officer

Offering amount: $7M
Amount sold: $4.4M
Minimum investment: $50K
Proceeds to insiders: $850K
First sale: Jan 2014
Incorporated: Corporation, Florida
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$1.8MraisedJan 2014 · 36 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Peter B. LangeExecutive Officer, Director
Brian DenommeExecutive Officer, Director
Michael HandleyExecutive Officer

Offering amount: $2M
Amount sold: $1.8M
Minimum investment: $5K
Proceeds to insiders: $54K
Placement agents: Futures Investment Company
First sale: Feb 2013
Incorporated: Corporation, Florida
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Regeneron NASDAQ: REGN www.regeneron.com20 shared keywordsRegeneron is a biotechnology company that develops medicines ranging from biologics to genetic medicines to treat serious diseases across areas such as metabolic disease, ophthalmology, and rare disease. The company focuses on research and development driven by human biology, with a clinical trial pipeline addressing conditions like generalized myasthenia gravis.

Companies competing with Reven Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Reven Pharmaceuticals do?: Reven is a biotech company developing RJX technology to address treatment needs for patients with limited therapeutic options. The company has conducted over a decade of research, including FDA-approved clinical studies and is currently investigating the technology's applications across multiple treatment modalities.
How much funding has Reven Pharmaceuticals raised?: Reven Pharmaceuticals has disclosed $6.3M raised across 2 rounds.
Where is Reven Pharmaceuticals headquartered?: Reven Pharmaceuticals is headquartered in Sarasota, US.